Recognition for Consilient Health Ireland at Menopause Workplace Excellence Awards 2024

Consilient Health Ireland is proud to be recognised as a leading employer in supporting menopausal and perimenopausal women. In partnership with The Menopause Hub Academy and Great Place to Work, the Menopause Workplace Excellence Awards honours organizations that are creating inclusive, supportive environments for employees experiencing menopause.

Our Menopause Policy is regularly updated and supported by a team of 10 Mental Health First Aiders (MHFAs), who are specially trained in menopause support. All managers receive annual training on both mental health and menopause, ensuring the policy remains a key component of our commitment to well-being and inclusion.

In addition, we promote Menopause in the Workplace Education through internal ‘lunch and learn’ sessions.

Our Menopause Policy is integral to our broader ongoing commitment to employee well-being and a supportive environment for all.

 

IE-CH-1637   Date of Preparation: October 20

Consilient Health announce the re-launch of Mysimba

Consilient Health are pleased to announce the re-launch of Mysimba, a prescription medicine which can help your patients achieve their weight loss goals.

Mysimba  is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (≥18 years) with an initial Body Mass Index (BMI) of;

  • ≥ 30 kg/m2 (obese), or
  • ≥ 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related co- morbidities e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension. 

Treatment with Mysimba should be discontinued after 16 weeks if patients have not lost at least 5% of their initial body weight.

Guidelines suggest the use of MYSIMBA in patients with overweight or obesity with emotional eating.1

Consider MYSIMBA for your patients with emotional eating as due to its mode of action in the brain it is designed to help to control hunger and cravings. 1, 2

Support tools including a Mode of Action Video, Patient Information Booklet, Physician Prescribing Checklist and Dose Card are available on Mysimba.ie.

Click here to view the Mysimba SPC on medicines.ie.

Consilient Health can be contacted at  irishoffice@consilienthealth.com or drugsafety@consilienthealth.com.

 

References:

  1. Chianelli et al, Italian guidelines for the management of adult individuals with overweight and obesity and metabolic comorbidities that are resistant to behavioral treatment, Journal of Endocrinological Investigation, 2023, www.medicines.ie.
  2. Acosta et al, Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic, Obesity (2021) 29, 662-671.

 

MYS-0364-001 10/24
IE-CH-1634
Date of Preparation: October 2024

 

OCON Therapeutics will cease the supply of Ballerine® in Ireland

We regret to inform you that OCON Therapeutics, manufacturer of the IUB Ballerine®, will cease the supply of Ballerine® in Ireland. Ballerine® is distributed by Consilient Health Ireland. This is an OCON business decision and does not impact supply of Ballerine® to other territories.

Consilient Health Ireland will continue to supply Ballerine® until the 31st of December 2024 and during this transition period will also support patients and Health Care Professionals who have been trained on Ballerine® insertion / removal.

Consilient Health can be contacted at  irishoffice@consilienthealth.com or drugsafety@consilienthealth.com. From the 31st of December, OCON will answer any queries from patients or HCPS (at support@oconmed.com).

If you have concerns or queries, please do not hesitate to contact Consilient Health Ireland at irishoffice@consilienthealth.com or drugsafety@consilienthealth.com  or OCON at support@oconmed.com.

 

Yours sincerely,

Deirdre Kelly

Country Manager Ireland and Malta

 

 

Job bag code: IE-CH-1534

Date of Preparation: March 2024

Consilient Health Ireland Wins Guaranteed Irish Award for the Pharmaceutical and MedTech Sector

On Thursday the 21st of March 2024, Consilient Health Ireland won the Guaranteed Irish Business Awards in the Pharmaceutical and MedTech Category. For 50 years, the licensed Guaranteed Irish symbol is the national symbol of trust and provenance for business in Ireland. This award is for companies who demonstrate excellent and innovative examples of how they incorporate the Guaranteed Irish core principles of Jobs, Community and Provenance into their day-to-day business, in a sustainable fashion.

Deirdre Kelly, Country Manager, and Luke Crosbie, Chief Executive say:
“We are delighted to receive this award. It is a testament to the support that we offer our staff and other stakeholders, not least the great work our team of mental health first aiders do to support our health and well-being as well as supporting a positive working environment at Consilient Health.”

Consilient Health is a privately owned pharmaceutical company, headquartered in Dublin. The company’s vision is to create value for all their stakeholders by bringing licensed pharmaceutical products to market. Being a sustainable business underpins everything we do at Consilient Health.

The company focuses on people, being responsible and remaining a competitive business.

Consilient Health Ireland can be contacted by emailing irishoffice@consilienthealth.com

 

Job bag code IE-CH-1549
Date of Preparation: March 2024

Consilient Health Ireland Named as one of the Best Workplaces™ in Pharma & Healthcare

Consilient Health Ireland is delighted that they have been recognised as one of the Best Workplaces in Pharma & Healthcare™ in 2023. This recognition is based on direct anonymised feedback from employees about the workplace experience.

Deirdre Kelly, Country Manager, and Luke Crosbie, Chief Executive say:

“We are delighted to receive this award, the Consilient Health team work hard to create a company culture where all employees can thrive and collaborate. This award also reflects the dedication of Consilient Health colleagues in promoting and supporting employee well- being and satisfaction.”

About Great Place to Work® and the Assessment Process

Great Place to Work® is the global authority on workplace culture. Since 1992, it has surveyed more than 100 million employees worldwide and used those deep insights to define what makes a great workplace: trust. Their employee survey platform empowers leaders with the feedback, real-time reporting, and insights they need to make data-driven people decisions. Everything they do is driven by the mission to build a better world by helping every organisation become a great place to work For All™.

Learn more at greatplacetowork.ie and on LinkedIn, Twitter, Facebook and Instagram

 

 

Job bag code IE-CH-1434 Date of Preparation: November 2023

Consilient Health Ireland Joins Guaranteed Irish

Consilient Health Ireland has been named a member of Guaranteed Irish. The official Guaranteed Irish licensed mark is awarded to businesses based in Ireland that support sustainable jobs and contribute to local communities.

Consilient Health is a privately owned pharmaceutical company, headquartered in Dublin. The company’s vision is to create value for all their stakeholders by bringing licensed pharmaceutical products to market. Being a sustainable business underpins everything we do at Consilient Health.

The company focuses on people, being responsible and remaining a competitive business.

Consilient Health Ireland can be contacted by emailing irishoffice@consilienthealth.com

IE-CH-1410 | Date of prep: October 2023